Renato Delascio Lopes, MD: Living In a New Era of Anticoagulant Therapy

AUGUST 29, 2016
Amy Jacob


Renato Delascio Lopes, MD, Duke University Medical Center, discussed at the European Society of Cardiology Congress 2016 (ESC), the progress of anticoagulant therapies for patients. He shared that in terms of his research, evaluating subgroups appeared to be beneficial, particularly in highlighting the consistency of results.  According to Lopes, while they have answered one question about apixaban, there are still many that are left unanswered to measure the efficacy of this drug in other sections and not just in atrial fibrillation. 

Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.